Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.460
+0.230 (5.44%)
Aug 3, 2026, 3:12 PM EDT - Market open
Ironwood Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Ironwood Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.35. The average 1-year stock price forecast is 42.38% higher than the current stock price, while the lowest is $3.70 (-17.04%) and the highest is $11 (+146.64%).
Price Target: $6.35 (+42.38%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 6, 2026.
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 5 | 4 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 15, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 | Hold | Maintains | $5 | +12.11% | May 6, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +124.22% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
460.13M
from 296.15M
Increased by 55.37%
Revenue Next Year
478.35M
from 460.13M
Increased by 3.96%
EPS This Year
1.09
from 0.25
Increased by 336.00%
EPS Next Year
1.44
from 1.09
Increased by 32.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.